Veeva Systems is a leading provider of industry-specific cloud solutions for the global life sciences industry. The company offers a comprehensive suite of software, data, and business consulting services designed to support critical functions from research and development through commercialization. Its platform enables life sciences companies to accelerate product development, manage regulatory compliance, and optimize sales and marketing effectiveness.
Based on Q2 2025 · FQ1 FY2026 filing
Cloud-based software and data solutions focused on the research, development, and quality management functions of life sciences companies. This segment supports clinical trial management, regulatory compliance, and quality control processes.
Veeva Development Cloud, Veeva Quality Cloud
Pharmaceutical companies, Biotechnology companies, Pre-commercial life sciences firms, Consumer health companies
Software and data analytics solutions designed to help life sciences companies market and sell their products more effectively. It includes customer relationship management and data-driven marketing insights.
Veeva Commercial Cloud, Veeva Data Cloud, Veeva CRM, Veeva Crossix
Life sciences commercial organizations, Marketing agencies, Pharmaceutical sales teams
Veeva is the dominant industry-specific cloud provider for life sciences, leveraging a deep vertical focus to compete against horizontal software providers.
North America, Europe, Global
Enterprise, Life Sciences, Biotechnology, Pharmaceuticals
Cloud infrastructure providers, Data providers, Third-party software developers
Global pharmaceutical companies, Emerging biotech firms, Medical device manufacturers, Contract research organizations
Crossix
Privacy-safe patient data and analytics provider acquired by Veeva
Common questions about Veeva Systems
Veeva Systems is a leading provider of industry-specific cloud solutions for the global life sciences industry. The company offers a comprehensive suite of software, data, and business consulting services designed to support critical functions from research and development through commercialization. Its platform enables life sciences companies to accelerate product development, manage regulatory compliance, and optimize sales and marketing effectiveness.
Veeva Systems (VEEV) has a market capitalization of $26.7B and trades on NYSE.
Veeva Systems generated $3.2B in trailing twelve-month revenue with net income of $908.9M, representing a net margin of 28.4%. Gross margin stands at 75.5%. These figures are based on the Q1 2026 filing.
Veeva Systems's key competitors include IQVIA Holdings Inc., Oracle Corporation, Microsoft Corporation, and others. These companies compete in similar markets and product categories.
Veeva Systems has approximately 7,172 employees.